Abstract
A new model of125I seed source, named OcuProsta seed, was designed and fabricated by Radiopharmaceuticals Division of Bhabha Atomic Research Centre for ophthalmic and interstitial applications. AAPM TG 43 recommended dosimetry parameters for this seed source were determined experimentally using TLD as well as by Monte Carlo (MC) simulation. Measured and MC calculated values of the dose rate constant (DRC) are 0.95±0.065 cGyh−1U−1 and 0.972±0.005 cGyh−1U−1, respectively. The mean of measured and calculated DRC (Λ=0.96 cGyh−1U−1) was recommended for the clinical dosimetry of OcuProsta seed. Measured and MC calculated radial dose function, g(r), anisotropy function, F(r,θ), anisotropy factor and anisotropy constants are also found to be in good agreement to each other. Dosimetry parameters of OcuProsta seed were compared with the published values of similar in-design125I seed sources. The DRC of BARC OcuProsta seed is very close to Amersham 6711 seed and is also comparable to the DRC of Best model 2301, Syncor PharmaSeed and Isotron selectSeed within the uncertainty of measurement/calculation. The g(r) of OcuProsta seed shows a difference of up to 10% in comparison to the g(r) values of the similar in-design seed sources. The values of anisotropy function of OcuProsta are 7 – 13% different from the anisotropy function of Amersham 6711 and Syncor PharmaSeed. The anisotropy constant of OcuProsta is close to Amersham 6711 seed while it is about 9% smaller than the anisotropy constant of Best model 2301 and Synchor PharmaSeed.
Similar content being viewed by others
References
Perez, C. A., Grigsby, P. W. and Williamson, J. F.,Clinical applications of brachytherapy: I. Low dose rate, in Principles and Practice of Radiation Oncology, 3rd ed., Lippincott-Raven, Philadelphia, 487–559, 1997.
Nori, D.,Conformal brachytherapy of prostate cancer: an effective outpatient treatment, Cancer Watch 1: 124–126, 1992.
Russel, K. J. and Blasko, J. C.,Recent advances in interstitial brachytherapy for localized prostate cancer, Probl. Urology 7: 260–278, 1993.
Nath, R., Anderson, L. L., Luxton, G., Weaver, K. A., Williamson, J. F. and Meigooni, A. S.,Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, Med. Phys. 22(2): 209–234, 1995.
Manolkar, R. B., Sane, S. U., Pillai, K. T. and Majali, M. A.,Comparison of method for preparation of 125 I source cores for the treatment of eye cancer, Appl. Radiat. Isot. 59: 145–150, 2003.
Williamson, J. F., Coursey, B. M., DeWerd, L. A., Hanson, W. F., Nath, R. and Ibbott, G.,Guidance to users of Nicomed Amersham and North American scientific Inc. I-125 Interstitial sources: Dosimetry and Calibration changes: recommendations of the AAPM RTC ad hoc Sub Committee on low energy seed dosimetry, Med. Phys. 26(4): 570–573, 1999.
International Atomic Energy Agency (IAEA),Calibration of photon and beta-ray sources used in brachytherapy, TECDOC-1274, IAEA, Vienna, Austria, 2002.
Karaiskos, P., Angelopoulos, A., Sakelliou, L., Sandilos, P., Antypas, C., Vlachos, L. and Koutsouveli, E.,Monte Carlo and TLD dosimetry of an 192 Ir high dose rate brachytherapy source, Med. Phys. 25: 1975–1984, 1998.
Pradhan, A. S. and Quast, U.,In-phantom response of LiF TLD-100 for dosimetry of 192 Ir HDR source, Med. Phys. 27: 1025–1030, 2000.
Nath, R., Meigooni, A. S. and Meli, J. A.,Dosimetry on the transverse axis of I-125 and Ir-192 interstitial brachytherapy sources, Med. Phys. 17: 1032–1040, 1990.
Wallace, R. E. and Fan, J. J.,Report on the dosimetry of a new design 125 Iodine brachytherapy source, Med. Phys. 26: 1925–1931, 2001.
Meigooni, A. S., Gearheart, D. M. and Sowards, K.,Experimental determination of dosimetric characteristics of Best 125 I brachytherapy source, Med. Phys. 27 (9): 2168–2173, 2000.
Popescu, C. C., Wise, J., Sowards, K., Meigooni, A. S. and Ibbott, G. S.,Dosimetric characteristics of the Pharma seed model BT-125-I source, Med Phys. 27(9): 2174–2181, 2000.
Meigooni, A. S., Meli, J. A. and Nath, R.,A comparison of solid phantoms with water for dosimetry of 125 I brachytherapy sources, Med. Phys. 15(5): 695–701, 1988.
Meigooni, A. S., Yoe-Sein, M. M., Al-Otoom, A. Y. and Sowards, K. T.,Determination of the dosimetric characteristics of InterSource125 Iodide brachytherapy source, Appl. Radiat. Isot. 56: 589–599, 2002.
Williamson, J. F. and Meigooni, A. S.,Brachytherapy Physics, Medical Physics Publishing, Madison, 88–133, 1995.
Luxton, G.,Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study, Med. Phys. 21: 631–641, 1994.
Los Alamos Monte Carlo Group,MCNP-A General Monte Carlo code for neutron and photon transport (version 3.1), 1983.
Hubbell, J. H. and Seltzer, S. M.,Tables of x-ray mass attenuation coefficients and mass energy absorption coefficients 1 keV to 20 MeV for Elements Z=1 to 92 and 48 additional substances of dosimetric interest, Technical Report NISTIR 5632, NIST, Gaithersburg, MD 20899, 1995.
International Commission on Radiological Protection,Radionuclide transformations: energy and intensity of Emissions, ICRP Report No. 38, 1983.
Rivard, M. J.,Refinements to the geometry factor used in the AAPM Task Group Report No. 43 necessary for brachytherapy dosimetry calculations, Med. Phys. 26: 2445–2450, 1999.
Williamson, J. F.,Comparison of measured and calculated dose rates in water near 125 I and 192 Ir seeds, Med. Phys. 18: 776–786, 1991.
Heintz, B. H., Wallace, R. E. and Hevezi, J. M.,Comparison of I-125 sources used for permanent interstitial implants, Med. Phys. 28(4): 671–682, 2001.
Anagnostopoulos, G., Baltas, D., Karaiskos, P., Sandilos, P., Papagiannis, P. and Sakelliou, L.,Thermoluminescent dosimetry of the SelectSeed 125 I interstitial brachytherapy seed, Med. Phys. 29(5): 709–715, 2002.
Karaiskos, P., Papagiannis, P., Sakelliou, L., Anagnostopoulos, G. and Baltas, D.,Monte Carlo dosimetry of SelectSeed 125 I interstitial brachytherapy seed, Med. Phys. 28(8): 1753–1760, 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, S.D., Basu, M., Shanta, A. et al. Dosimetry parameters of BARC OcuProsta I-125 seed source. Australas. Phys. Eng. Sci. Med. 28, 14 (2005). https://doi.org/10.1007/BF03178859
Received:
Accepted:
DOI: https://doi.org/10.1007/BF03178859